Brief: Agile Therapeutics Announces Preliminary Expectations For First Quarter 2023
28/04/2023 14:10
Agile Therapeutics Inc AGRX.O :
* AGILE THERAPEUTICS ANNOUNCES PRELIMINARY EXPECTATIONS FOR
FIRST
QUARTER 2023
* AGILE THERAPEUTICS INC - Q1 2023 NET REVENUE IS EXPECTED
TO BE
IN RANGE OF $3.8 TO $4.0 MILLION
Source text for Eikon: ID:nGNX51HK8v
Further company coverage: AGRX.O
Recent news on Agile Therapeutics
See all newsBrief: Agile Therapeutics Inc. Announces Definitive Merger Agreement With Insud Pharma, S.L.
Agile Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Agile Therapeutics Announces Delisting From Nasdaq
Agile Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: Agile Therapeutics Completes Pay-Off Of Debt